Advanced Filters
noise

Tokyo and Other Japanese City, Japan Clinical Trials

A listing of Tokyo and Other Japanese City, Japan clinical trials actively recruiting patients volunteers.

Found 61,726 clinical trials
C Chun-Feng Liu, Ph.D, MD

A Study on the Safety and Tolerability of RGL-193 in Patients With Advanced Parkinson's Disease

A safety study in patients with Parkinson's disease.

45 - 70 years of age All Phase N/A
A Abramson Cancer Center Clinical Trials Service

CD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AML

The purpose of this study is to provide a new type of treatment for AML. This treatment combines a new type of stem cell transplant along with treatment using chimeric antigen receptor (CAR) T cells that have been engineered to recognize and attack your AML cells. The first treatment is …

18 years of age All Phase 1
U Umang Swami

Bortezomib in Patients With Metastatic Castration-Resistant Prostate Cancer With PTEN Deletion

The goal of this clinical trial is to test the anti-tumor activity of bortezomib in participants with Metastatic Castration Resistant Prostate Cancer (mCRPC) with PTEN Deletion. The main question[s] it aims to answer is if the use of bortezomib will result in a decline in PSA for participants. Participants will …

18 years of age Male Phase 2
J Jørn M Helge, PhD

Effect of Obesity on Extracellular Matrix Composition

The experiment is a simple cross-sectional study with three groups (n=10) in each group, young and old healthy men and obese young men. The study will investigate the composition of the adipose tissue extra cellular matrix. The main questions to answer, is there differences in the adipose tissue extracellular matrix …

18 - 75 years of age Male Phase N/A

A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC

This is a multicenter, open-label, Phase 2 study. The study will enroll subjects with metastatic castration-resistant prostate cancer (mCRPC) previously treated with at least 1 prior line of novel hormone therapy (NHT). NHT includes abiraterone, enzalutamide, apalutamide, darotamide, or rezvilutamide. Subjects must have received no more than 2 prior lines …

18 years of age Male Phase 2

To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307

To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307, Autologous Glypican 3 (GPC3) Targeted Chimeric Antigen Receptor T cell therapy in Patients with GPC3 Positive Advanced Hepatocellular Carcinoma who Have Failed Standard Therapy

19 years of age All Phase 1
R Rabia Nur Doğan

Evaluation of the Effect of Music Medicine Application on Menstrual Symptoms

In this study, the "Music Medicine Application" method was chosen in line with the literature and guidelines and it is aimed to determine whether it is effective in reducing the symptoms experienced by female students with "Music Medicine Application" during the menstrual period.

years of age Female Phase N/A

Syndesmotic Screw in Neutral Position Versus Maximum Ankle Dorsiflexion in Ankle Fractures; Comparative Study.

Ankle fracture is one of the most common orthopedic injuries. Approximately, 20% of surgically treated ankle fractures are associated with syndesmotic instability.According to the mechanism of the injury the syndesmotic disruption should be considered in Danis-Weber C-type fractures. However, such injuries were also frequently seen in Danis-Weber B-type fractures. Failure …

18 - 70 years of age All Phase N/A
Y Yasemin Şara, MSc

Program Based on the Family-Centered Empowerment Model on Total Knee Prosthesis Patients and Their Caregivers

In this study, the family empowerment model program given to individuals who underwent Total Knee Prosthesis and their caregivers was examined on the individuals' physiological function level, self-efficacy, and post-discharge hospital readmission (during the follow-up period); It was aimed to determine the effect of caregivers on their care burden, caregiving …

18 years of age All Phase N/A
V Vijaya Vemulakonda, MD, JD

Decision Aid for Parents of Infants With UPJO

Ureteropelvic junction obstruction (UPJO) is the most common etiology of high-grade hydronephrosis, affecting approximately 4,000-10,000 infants annually in the U.S. The goal of surgical treatment of UPJO is to minimize the risk of kidney damage associated with obstruction, which may occur in 30-60% of infants with high-grade hydronephrosis.1-However, the benefit …

18 - 89 years of age All Phase N/A

Simplify language using AI